Cargando…
Intrapleural targeted therapies (anti-VEGF and anti-EGFR) in the model of malignant pleural effusion
RATIONALE: Malignant pleural effusion has few options of treatment and drugs administrated by different routes can lead to a less permissive microenvironment for the development of malignant pleural disease. OBJECTIVES: To analyze therapies administered intrapleurally in malignant pleural disease an...
Autores principales: | Acencio, Milena Marques Pagliarelli, Puka, Juliana, Alvarenga, Vanessa Adélia, Martins, Vanessa, de Carvalho, Mariana Lombardi Peres, Marchi, Evaldo, Capelozzi, Vera Luiza, Teixeira, Lisete Ribeiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739623/ https://www.ncbi.nlm.nih.gov/pubmed/29285236 http://dx.doi.org/10.18632/oncotarget.21362 |
Ejemplares similares
-
A modified experimental model of malignant pleural disease induced by lung Lewis carcinoma (LLC) cells
por: Acencio, Milena Marques Pagliarelli, et al.
Publicado: (2015) -
Evaluation of cellular alterations and inflammatory profile of mesothelial cells and/or neoplastic cells exposed to talc used for pleurodesis
por: Acencio, Milena Marques Pagliarelli, et al.
Publicado: (2020) -
Intrapleural Tenecteplase for Complicated Parapneumonic Pleural Effusion
por: Kadhem, Husain, et al.
Publicado: (2021) -
Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion
por: Li, Xinying, et al.
Publicado: (2021) -
Influence of the progression of pleural neoplasia on the outcome of pleurodesis in mice
por: Sabbion, Rodrigo Olivio, et al.
Publicado: (2020)